国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
METFORMIN HCL (EQ TO METFORMIN HYDROCHLORIDE)
台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610)
A10BA02
緩釋錠
METFORMIN HCL (EQ TO METFORMIN HYDROCHLORIDE) (6820400710) MG
鋁箔盒裝
製 劑
須由醫師處方使用
MERCK SANTE S.A.S. – CENTRE DE MEYZIEU 10 AVENUE DE LATTRE DE TASSIGNY 69330 MEYZIEU - FRANCE FR
metformin
第二型糖尿病。說明:1.成人患者於充足飲食控制及運動皆無法達到理想的血糖控制下,可選擇Glucophage XR 作為其輔助療法。2.單獨服用或與其他口服降血糖藥物或胰島素併用。
註銷日期: 2017/04/12; 註銷理由: 自請註銷; 有效日期: 2017/09/19; 英文品名: Glucophage XR 1000mg Prolonged Release Tablets
已註銷
2012-09-19
CompositionEach Glucophage XR 500 mg prolonged release tablet contains as active ingredient 500 mg metformin hydrochloride (equivalent to 390 mg of metformin base). Excipients Magnesium stearate, sodium carboxymethyl cellulose, hypromellose, and microcrystalline cellulose. 阅读完整的文件Each Glucophage XR 750 mg prolonged release tablet contains as active ingredient 750 mg metformin hydrochloride (equivalent to 585 mg of metformin base). Excipients Magnesium stearate, sodium carboxymethyl cellulose, hypromellose. Each Glucophage XR 1000 mg prolonged release tablet contains as active ingredient 1000 mg metformin hydrochloride (equivalent to 780 mg of metformin base). Excipients: Magnesium stearate, sodium carboxymethyl cellulose, hypromellose. PROPERTIES Glucophage XR is an antidiabetic medicine that belongs to the group of biguanides. Metformin, the active ingredient in Glucophage XR, reduces hepatic glucose production, increases insulin sensitivity in muscles and delays intestinal glucose absorption. A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with Glucophage immediate- release as first-line therapy after diet therapy. Glucophage is associated with either a stable body weight or modest weight loss. INDICATION Type 2 DM 1. Glucophage XR is used for the treatment of type 2 diabetes in adults as an adjunct to adequate diet and exercise. 2. Glucophage XR may be given alone, or with other oral antidiabetic agents, or with insulin. CONTRAINDICATIONS Glucophage XR MUST NOT BE USED in the following cases: • hypersensitivity to metformin hydrochloride or any of the excipients • severe destabilisation of diabetes with either pre-coma or ketoacidosis (a condition caused by substances called ‘ketone bodies’ accumulating in the blood; symptoms include stomach pain, fast and deep breathing, sleepiness or unusual fruity odour of the breath) • renal insufficiency, as suggested by serum cleatinine leve